Marathon Asset Management (UK)’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Marathon Asset Management (UK)'s ELV Position: Q2 2026 in Review
Marathon Asset Management (UK) reduced its Elevance Health (ELV) stake by 18% in Q2 2026, selling an estimated $18.1M and leaving 219,490 shares worth $84.9M. The position accounts for 3.45% of the portfolio, ranked #6.
Marathon Asset Management (UK) first reported a position in ELV in Q2 2013 and has held it in 14 quarters since. The position peaked at $105M in Q1 2025. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Marathon Asset Management (UK) held 219,490 shares of Elevance Health worth $84.9M as of Q2 2026.
- Marathon Asset Management (UK) sold 48,898 Elevance Health shares in Q2 2026, an estimated $18.1M.
- Elevance Health made up 3.45% of Marathon Asset Management (UK)'s portfolio in Q2 2026, its #6 holding.
- Marathon Asset Management (UK) first reported a position in Elevance Health in Q2 2013 and has held it in 14 quarters since.
- Marathon Asset Management (UK)'s Elevance Health position peaked at $105M in Q1 2025.
- 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Marathon Asset Management (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.